Omadacycline drug susceptibility testing for non-tuberculous mycobacteria using oxyrase to overcome challenges with drug degradation.
Gunavanthi D BoorgulaTawanda GumboSanjay SinghPamela J McShaneJulie V PhilleyShashikant Srivastava
Published in: Tuberculosis (Edinburgh, Scotland) (2024)
Use of 0.5 % oxyrase could be a potential solution to reliable and reproducible omadacycline MIC of Mab. However, oxyrase demonstrated a variable effect in reducing MICs against MAC and Mkn.